Insight & Intelligence

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 15, 2017 (Vol. 37, No. 20)

Raising the Bar of Cell Line Authentication

Researchers May Be Slow to Implement Protocols Unless They Are Pressured

  • Imagine publishing a paper, accepting a research grant, or recruiting patients for a clinical trial only to discover that the esophageal cancer cell line used in your disease model actually came from a different tumor type. It’s a scientist’s nightmare, but it became an unfortunate reality for researchers working ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.